Guangzhou Pharmaceutical Holdings Limited: "15th Five-Year Plan" plans to invest 20 billion yuan in research and development, 30 billion yuan in industrial mergers and acquisitions, and pipeline cooperation.

At the first "Great Power New Drug" global conference held from July 22nd to 24th, Peng Wei, Vice General Manager of Guangzhou Pharmaceutical Group, launched an invitation to global high-quality scientific research BD pipeline cooperation projects. He stated that Guangzhou Pharmaceutical Group is actively building a dual-drive pattern of "self-research + mergers and acquisitions", with a plan to invest 20 billion yuan in research and development during the "13th Five-Year Plan" period, 30 billion yuan for industrial mergers and acquisitions and pipeline cooperation, striving to achieve results within 1-2 years for acquisitions, 3-5 years for pipeline acquisitions, and 5-10 years for self-research investment.